Surgical outcomes after neoadjuvant radiotherapy for lung cancer depending on pneumonitis.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00038039

Enrollment

500

Registered

2025-12-03

Start date

2025-12-15

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C34

Interventions

Group 1: Retrospective analysis of patients who received an anatomic resection of lung cancer following neoadjuvant radiotherapy between January 01, 2016 and December 31, 2024.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - anatomic resection after neoadjuvant radiotherapy in non-small cell lung cancer - time period: January 1, 2016 to December 31, 2024

Exclusion criteria

Exclusion criteria: treatment as part of a prospective study

Design outcomes

Primary

Measure	Time frame
Postoperative mortality and morbidity in relation to the occurrence of pneumonitis.	—

Secondary

Measure	Time frame
Overall survival in relation to the occurrence of pneumonitis.	—

Countries

Germany

Contacts

Public ContactNatalie Baldes

Universitätsmedizin Essen-Ruhrlandklinik, Klinik für Thoraxchirurgie und Thorakale Endoskopie

natalie.baldes@rlk.uk-essen.de+492014334022

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026